Could Coca Leaf Be The Next Big Thing?
The stories about “health” products and energy tonics of the late 1800s and early 1900s aren’t wholly exaggerated. Coca leaf was a prominent player in many such products, before we began to prohibit it. But with many other drugs heading to new understandings and possible de-scheduling, might the coca leaf be also headed for a resurgence? Coca is what this Trade to Black podcast with Pat McCutcheon, Chairman and CEO of Power Leaves Corp, is all about.
Though coca had been introduced to Europe in the 1600s, it wasn’t until the mid 19th century that Europeans really understood that the leaves of the coca plant had some pretty interesting pharmacological properties. And yes, it’s true: the early version of Coca-Cola did indeed contain cocaine. It wasn’t long after the turn of the 20th century that most of these products became illegal after the addictive nature of cocaine came to light.
But did the west bar a useful substance too soon, before we understood how to utilize it better? After all, there are records of Peruvians using coca leaves for approximately 8000 years.
Investors might recognize the name of Pat McCutcheon; he’s the former CEO of MediPharm, one of the largest cannabis oil producers in the world. He gives us an interesting overview into a potential new, lucrative industry, and explains how it differs from other ventures in substances such as cannabis.
McCutcheon explains the interesting potential medicinal benefits that could come from the coca leaf, and how it could enter the market safely thanks to a process of de-cocanization. Is there a potential market to make health products from coca? And what would cultivation look like, especially in the framework of current regulation for cannabis?
Tune in as McCutcheon walks us through the concept of pioneering the next “business mammoth” and how commercialization and even NASDAQ listing could potentially happen as soon as 2024 if Power Leaves Corp can successfully implement their plans to become the next bullish sector.
